Predictors of Patient-Reported Outcomes at 2 Years After Revision Anterior Cruciate Ligament Reconstruction.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 19 7 2019
medline: 9 6 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Patient-reported outcomes (PROs) are a valid measure of results after revision anterior cruciate ligament (ACL) reconstruction. Revision ACL reconstruction has been documented to have worse outcomes when compared with primary ACL reconstruction. Understanding positive and negative predictors of PROs will allow surgeons to modify and potentially improve outcome for patients. The purpose was to describe PROs after revision ACL reconstruction and test the hypothesis that patient- and technique-specific variables are associated with these outcomes. Cohort study; Level of evidence, 2. Patients undergoing revision ACL reconstruction were identified and prospectively enrolled by 83 surgeons over 52 sites. Data included baseline demographics, surgical technique and pathology, and a series of validated PRO instruments: International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index, and Marx Activity Rating Scale. Patients were followed up at 2 years and asked to complete the identical set of outcome instruments. Multivariate regression models were used to control for a variety of demographic and surgical factors to determine the positive and negative predictors of PRO scores at 2 years after revision surgery. A total of 1205 patients met the inclusion criteria and were successfully enrolled: 697 (58%) were male, with a median cohort age of 26 years. The median time since their most recent previous ACL reconstruction was 3.4 years. Two-year questionnaire follow-up was obtained from 989 patients (82%). The most significant positive predictors of 2-year IKDC scores were a high baseline IKDC score, high baseline Marx activity level, male sex, and having a longer time since the most recent previous ACL reconstruction, while negative predictors included having a lateral meniscectomy before the revision ACL reconstruction or having grade 3/4 chondrosis in either the trochlear groove or the medial tibial plateau at the time of the revision surgery. For KOOS, having a high baseline score and having a longer time between the most recent previous ACL reconstruction and revision surgery were significant positive predictors for having a better (ie, higher) 2-year KOOS, while having a lateral meniscectomy before the revision ACL reconstruction was a consistent predictor for having a significantly worse (ie, lower) 2-year KOOS. Statistically significant positive predictors for 2-year Marx activity levels included higher baseline Marx activity levels, younger age, male sex, and being a nonsmoker. Negative 2-year activity level predictors included having an allograft or a biologic enhancement at the time of revision surgery. PROs after revision ACL reconstruction are associated with a variety of patient- and surgeon-related variables. Understanding positive and negative predictors of PROs will allow surgeons to guide patient expectations as well as potentially improve outcomes.

Sections du résumé

BACKGROUND
Patient-reported outcomes (PROs) are a valid measure of results after revision anterior cruciate ligament (ACL) reconstruction. Revision ACL reconstruction has been documented to have worse outcomes when compared with primary ACL reconstruction. Understanding positive and negative predictors of PROs will allow surgeons to modify and potentially improve outcome for patients.
PURPOSE/HYPOTHESIS
The purpose was to describe PROs after revision ACL reconstruction and test the hypothesis that patient- and technique-specific variables are associated with these outcomes.
STUDY DESIGN
Cohort study; Level of evidence, 2.
METHODS
Patients undergoing revision ACL reconstruction were identified and prospectively enrolled by 83 surgeons over 52 sites. Data included baseline demographics, surgical technique and pathology, and a series of validated PRO instruments: International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Western Ontario and McMaster Universities Osteoarthritis Index, and Marx Activity Rating Scale. Patients were followed up at 2 years and asked to complete the identical set of outcome instruments. Multivariate regression models were used to control for a variety of demographic and surgical factors to determine the positive and negative predictors of PRO scores at 2 years after revision surgery.
RESULTS
A total of 1205 patients met the inclusion criteria and were successfully enrolled: 697 (58%) were male, with a median cohort age of 26 years. The median time since their most recent previous ACL reconstruction was 3.4 years. Two-year questionnaire follow-up was obtained from 989 patients (82%). The most significant positive predictors of 2-year IKDC scores were a high baseline IKDC score, high baseline Marx activity level, male sex, and having a longer time since the most recent previous ACL reconstruction, while negative predictors included having a lateral meniscectomy before the revision ACL reconstruction or having grade 3/4 chondrosis in either the trochlear groove or the medial tibial plateau at the time of the revision surgery. For KOOS, having a high baseline score and having a longer time between the most recent previous ACL reconstruction and revision surgery were significant positive predictors for having a better (ie, higher) 2-year KOOS, while having a lateral meniscectomy before the revision ACL reconstruction was a consistent predictor for having a significantly worse (ie, lower) 2-year KOOS. Statistically significant positive predictors for 2-year Marx activity levels included higher baseline Marx activity levels, younger age, male sex, and being a nonsmoker. Negative 2-year activity level predictors included having an allograft or a biologic enhancement at the time of revision surgery.
CONCLUSION
PROs after revision ACL reconstruction are associated with a variety of patient- and surgeon-related variables. Understanding positive and negative predictors of PROs will allow surgeons to guide patient expectations as well as potentially improve outcomes.

Identifiants

pubmed: 31318611
doi: 10.1177/0363546519862279
pmc: PMC7335592
mid: NIHMS1594053
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2394-2401

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR060846
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Am J Sports Med. 2011 Sep;39(9):1889-93
pubmed: 21646434
J Knee Surg. 2005 Jan;18(1):69-72
pubmed: 15742600
J Bone Joint Surg Am. 2005 Aug;87(8):1671-2
pubmed: 16085603
Am J Sports Med. 2013 Jul;41(7):1571-8
pubmed: 23698386
Am J Sports Med. 2006 Dec;34(12):2026-37
pubmed: 17092921
Knee Surg Sports Traumatol Arthrosc. 2015 Aug;23(8):2339-2348
pubmed: 24850239
J Bone Joint Surg Am. 2012 Mar 7;94(5):468-77
pubmed: 22398742
Am J Sports Med. 2011 Jan;39(1):199-217
pubmed: 20709943
J Bone Joint Surg Am. 2005 Aug;87(8):1673-9
pubmed: 16085604
J Bone Joint Surg Am. 2012 Feb 1;94(3):277-85
pubmed: 22298061
Knee Surg Sports Traumatol Arthrosc. 2010 Jan;18(1):98-105
pubmed: 19784630
Am J Sports Med. 2016 Jul;44(7):1671-9
pubmed: 27161867
J Am Acad Orthop Surg. 2010 Jul;18(7):436-44
pubmed: 20595136
Am J Sports Med. 2012 Apr;40(4):808-14
pubmed: 22374942
Am J Sports Med. 2010 Oct;38(10):2040-50
pubmed: 20709944
Am J Sports Med. 2015 Jul;43(7):1616-22
pubmed: 25899434
Osteoarthritis Cartilage. 2015 Oct;23(10):1674-84
pubmed: 26072385
J Bone Joint Surg Am. 2012 Mar 21;94(6):531-6
pubmed: 22438002
Am J Sports Med. 2014 Oct;42(10):2301-10
pubmed: 25274353
J Knee Surg. 2013 Aug;26(4):239-47
pubmed: 23404491
J Knee Surg. 2016 Aug;29(6):458-63
pubmed: 26588108
J Knee Surg. 2007 Oct;20(4):308-11
pubmed: 17993075
Am J Sports Med. 2017 Sep;45(11):2586-2594
pubmed: 28696164
Am J Sports Med. 2011 Feb;39(2):348-59
pubmed: 21084660
Am J Sports Med. 2004 Dec;32(8):1986-95
pubmed: 15572332
Arthritis Rheum. 2003 Aug;48(8):2178-87
pubmed: 12905471
Am J Sports Med. 2010 Oct;38(10):1979-86
pubmed: 20889962
J Am Acad Orthop Surg. 2009 Jan;17(1):31-9
pubmed: 19136425

Auteurs

All authors are listed in the Authors section at the end of this article.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH